(American College of Rheumatology) Rheumatoid arthritis patients in remission may experience more successful tapering of their biologic drugs if they meet a certain set of factors, including younger age, no concomitant steroid use, and low level of serum CRP, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2y1gM7L
No comments:
Post a Comment